Africa: Modified Risk Tobacco Product - Historic FDA Decision and Lessons for Africa
Following 43 months of evaluation, the U.S. Food and Drug Administration (FDA) on 7 July authorized the marketing of IQOS in the country, Philip Morris International’s (PMI) electrically heated tobacco system, as a modified risk tobacco product (MRTP). The finding recognizes the harm-reduction effects of the “heat-not-burn” technology, which provides smokers with nicotine, while substantially reducing the risks associated with the combustion of conventional cigarettes. While rates of smoking have decreased in wealthy countries, they have grown in poorer nations. In sub-Saharan Africa, cigarette consumption increased by over 50 percent between 1980 and 2016. Of deaths among African adults caused by second-hand smoke, over 60 percent are among women who live and work with smokers. Six lessons can be learned from the decision by the USFDA and similar regulatory bodies in Europe (...)
Thursday, July 16, 2020
Tobacco smoking in three “left behind” subgroups: indigenous, the rainbow community and people with mental health conditions
This paper aims to investigate the extent to which three subgroups – people with mental health conditions, people belonging to sexual minority and gender groups and Indigenous peoples – have been ‘‘left behind’’ by countries implementing the World Health Organization’s Framework Convention on Tobacco Control. The World Health Organization’s (WHO) Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020 target is to reduce the prevalence of current tobacco use by 30% in persons aged 15 and older between 2010 and 2025 [...]
Tuesday, July 14, 2020
Tobacco harm reduction in the 21st century
This paper aims to overview the need for tobacco harm reduction, the consumer products that facilitate tobacco harm reduction and the barriers to its implementation. The worldwide endemic of tobacco smoking results in the death of over seven million smokers a year. Cigarette quit rates are very low, from 3%–12%, and relapse rates are high, from 75%–80% in the first six months and 30%– 40% even after one year of abstinence. In addition, some smokers do not desire to quit. Cigarette substitution in tobacco harm reduction is one strategy that may reduce the burden of morbidity and mortality.
Tuesday, July 14, 2020
Vaping easing'historic momentfor public health'
Governments worldwide should not ban alternative smoking products, or they will miss an "enormous" opportunity to phase out traditional cigarettes, tobacco giant Philip Morris warned.
This came as the US Food and Drug Administration gave the company approval last week to market its four heat-not-burn tobacco devices as "modified risk tobacco products."
Philip Morris International chief executive Andre Calantzopoulos called the authorization a "historical moment" for public health.
"For so many years, tobacco control policies have focused on restrictive measures in order to convince people to quit [smoking]," he said, [...]
Monday, July 06, 2020
Lies, Hypocrisy and Bluster
An employee of the magazine PR Week has been happy to trot out another unwarranted attack on the Foundation for a Smoke-Free World (FSFW), courtesy of the “tobacco industry watchdog”, Stopping Tobacco Organizations and Products (STOP). STOP, synonymous with the University of Bath’s ‘Tobacco Tactics’, is part of a coordinated approach to undermine tobacco harm reduction (THR) through slur and innuendo rather than address the actual science. Bloomberg’s money works hard at STOP. Recently, one of the researchers at Bath contacted the Planet of the Vapes forum in order to gain assistance with “research”. The latest attack says that the World Health Organization is “concerned” by a “Big Tobacco-funded aggressive PR effort” during the current COVID-19 pandemic. They claim the FSFW is pulling strings in order to get its minions to conduct “research on tobacco users”. (...) STOP says FSFW funds “VIDA News to ‘increase public awareness of the drivers of smoking harm and the availability of alternatives’ [and] the International Network of Nicotine Consumer Organisations (INNCO) to ‘promote tobacco harm-reduction on the global stage’.”
Friday, July 03, 2020
20% of Smoking-related Cancer Survivors Continue to Smoke, Study Finds
Nearly 20 percent of survivors of smoking-related cancers continued to smoke even after recovery, according to a study published Thursday by JAMA Network Open. The percentage was far greater among survivors of all types of cancer who had been smokers. More than half -- 56 percent -- remained active smokers, they said. "The percentage of current smokers among smoking-related cancer survivors was substantially higher than that in the general population of about 14 percent," study co-author Sanjay Shete told UPI.